Literature DB >> 24167703

Life-threatening haematemesis associated with clozapine: a case report and literature review.

Kazeem Olaide Adebayo1, Nurudeen Ibrahim, Temilola Mosanya, Benjamin Eegunranti, Babatunde Suleiman, Akeem Ayankunle.   

Abstract

Clozapine is regarded as a second-line and in some cases last-line antipsychotic known for its common life-threatening side effects, such as agranulocytosis, constipation and cardiomyopathies, but rarely haematemesis. We report a case of severe haemetemesis in a chronic schizophrenic patient managed with clozapine. The patient was a 46-year-old male being managed for chronic schizophrenia with treatment resistance who developed sudden severe haematemesis following commencement of clozapine for 6 weeks. The patient had 1.1 l of blood transfusion. The relevant literature is reviewed. Clozapine can be associated with a life-threatening haematemesis. Psychiatrists and other medical specialists need to be alert to the fatality of clozapine-induced haematemesis in the treatment of psychiatric disorders.

Entities:  

Keywords:  clozapine; haematemesis; schizophrenia

Year:  2013        PMID: 24167703      PMCID: PMC3805384          DOI: 10.1177/2045125313481026

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  13 in total

Review 1.  Death from clozapine-induced constipation: case report and literature review.

Authors:  Tomer T Levin; Jonathan Barrett; Alan Mendelowitz
Journal:  Psychosomatics       Date:  2002 Jan-Feb       Impact factor: 2.386

Review 2.  Clozapine safety, 35 years later.

Authors:  Michele Raja
Journal:  Curr Drug Saf       Date:  2011-07

3.  Use of antacid medication in patients receiving clozapine: a comparison with other second-generation antipsychotics.

Authors:  David Taylor; Olubanke Olofinjana; Tamanna Rahimi
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

4.  Mortality in current and former users of clozapine.

Authors:  A M Walker; L L Lanza; F Arellano; K J Rothman
Journal:  Epidemiology       Date:  1997-11       Impact factor: 4.822

5.  Gastroesophageal reflux as a possible result of clozapine treatment.

Authors:  R W Baker; K N Chengappa
Journal:  J Clin Psychiatry       Date:  1998-05       Impact factor: 4.384

6.  Reflux oesophagitis and clozapine.

Authors:  M K Laker; J C Cookson
Journal:  Int Clin Psychopharmacol       Date:  1997-01       Impact factor: 1.659

Review 7.  A review of clozapine safety.

Authors:  Joanna Fitzsimons; Michael Berk; Timothy Lambert; Michel Bourin; Seetal Dodd
Journal:  Expert Opin Drug Saf       Date:  2005-07       Impact factor: 4.250

8.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

9.  Life-threatening constipation associated with clozapine.

Authors:  Sanil Rege; Tim Lafferty
Journal:  Australas Psychiatry       Date:  2008-06       Impact factor: 1.369

10.  Case report: rapidly fatal bowel ischaemia on clozapine treatment.

Authors:  Giles Townsend; David Curtis
Journal:  BMC Psychiatry       Date:  2006-10-19       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.